Watson Pharmaceuticals, Inc. (WPI) Tops Q4 EPS by 1c; Guides FY12 EPS

February 14, 2012 7:01 AM EST Send to a Friend
Watson Pharmaceuticals, Inc. (NYSE: WPI) reported Q4 EPS of $1.77, $0.01 better than the analyst estimate of $1.76. Revenue for the quarter came in at $1.55 billion versus the consensus estimate of $1.54 billion.

Watson Pharmaceuticals, Inc. sees FY2012 EPS of $5.50-$5.80, versus the consensus of $5.60.

For earnings history and earnings-related data on Watson Pharmaceuticals, Inc. (WPI) click here.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment